The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Yale study explains complex infection fighting mechanism

Yale School of Medicine researchers report in Nature Immunology how infection fighting mechanisms in the body can distinguish between a virus and the healthy body, shedding new light on auto immune disorders.

The infection fighters in question, toll-like receptors (TLRs), function by recognizing viral, bacterial or fungal pathogens and then sending signals throughout the immune system announcing that an infection has occurred.

Viruses change features to avoid being recognized, thereby triggering the immune response. But TLRs recognize the highly conserved features of pathogens, features that are often difficult to change without affecting the punch of the pathogen, said lead author of the study, Gregory Barton of the University of California at Berkeley who performed the research while in the Section of Immunobiology at Yale School of Medicine.

He said that one exception to the general view of how TLRs work is the way TLRs recognize viruses since viruses lack the unique features of bacterial or fungal pathogens. Because of this, the immune system has had to find other ways to recognize viral infection.

"In particular, the DNA or RNA that comprise viral genomes can stimulate certain TLRs," Barton said. "This strategy comes at an enormous cost. By targeting the DNA or RNA of viruses, the immune system runs the risk of accidentally recognizing its own DNA and RNA as foreign and inappropriately making an immune response against itself. This autoimmune condition is called systemic lupus erythematosus or SLE, and can be devastating for those unfortunate enough to suffer from it."

The work of senior author Ruslan Medzhitov, professor of immunobiology, and his colleagues, has focused on trying to understand how recognition of a body's own DNA is avoided by those TLRs involved in viral nucleic acid recognition.

"We have known for some time that those TLRs are sequestered in specialized compartments within cells," Barton sa
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
10-Jan-2006


Page: 1 2

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New study counts the economic cost of persistent pain in Australia
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Most seniors now have drug coverage, U-M study shows
7. To gain muscle and lose fat, drink milk: study
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Even older women at high risk have little interest in being tested for HIV, study finds
10. Metabolic study in mice could lead to good cholesterol boosters
11. Michigan-CDC study supports value of social restrictions during influenza pandemics

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Yale study explains complex infection fighting mechanism

(Date:11/24/2009)...ov.24/PRNewswire/--Mostpeoplelookforwardtokickingo...getherwithfriendsandfamily.TheMacombCountyHealthDe...gtheholidays.Travelingandbeinginlargegroupsareeasy...ayhealthy: ,, VACCINATION ,, Thefirstandmo...togetvaccinatedagainsttheH1N1strainoftheflu.TheMac...
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarew...pingHispanic-AmericanseniorsunderstandthebasicsofM...takeafreeZumba®Goldclass,aLatin-infusedfitnes...a,rumba,andtango. ,, UnitedHealthcarewilloffert...andengagedwhenlearningabouttheirhealthcareoptions....
(Date:11/24/2009)...Newswire-FirstCall/--CenteneCorporation(NYSE: CNC ...dhasselectedCenteneasoneoftwoCoordinatedCareOrgani...essNetwork(MississippiCAN),acoordinatedcareprogram...ngwiththeDivisiontoexecuteacontractinwhichthecompa...noliaHealthPlan(Magnolia). ,, BasedinJackson,Mi...
(Date:11/24/2009)...the falls that plague older adults, study finds, ... Falls are a leading cause of death among older Am...in contributes to those accidents. , "Pain cont... and is associated with mobility limitations that .... , "Chronic pain, no matter how we measured it...
(Date:11/24/2009)...ewswire-USNewswire/--TheAmericanDentalAssociation(...nnewdentalteammembersaspartofapilotprogramtoimprov...ommunityDentalHealthCoordinator(CDHC)isamemberofth...tshavelimitedaccesstodentalcaretoimprovetheiroralh...ivedentalcareservices--includingscreeningsandfluor...
Breaking Medicine News(10 mins):Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
(Date:11/24/2009)...ov.24/PRNewswire/--ZargisMedicalCorp.,asubsidiaryo...sCorporateResearch(NYSE: SI ),todayannouncedthatit...2009episodeofCBS, TheEarlyShow duringasegmentinwhi...eviewedfivewinningproductsfromthepublication,s2009...dely-viewedtelevisionmorningnewstalkshowbroadcastb...
(Date:11/24/2009)...PRNewswire/--AmbitBiosciencesCorporationannouncedt...AC220,anovelsecondgenerationFLT3inhibitor,inAMLatt...)tobeheldinNewOrleans,LA,December5-8,2009.Anoralpr...lPhaseImonotherapysafetystudyinadultswithacutemyel...bepresentedevaluatingtheeffectofAC220monotherapyan...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--EchoTherapeutics,Inc....e-freeSymphony(TM)tCGMSystemasanon-invasive,wirele...temanditsPrelude(TM)SkinPrepSystemfortransdermaldr...ChairmanandChiefExecutiveOfficer,willpresentatthe1...nce,sponsoredbytheNewYorkSocietyofSecuritiesAnalys...
Breaking Medicine Technology:Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 1YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 4Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35
Other News:
...ons cause neurodegenerative diseases in humans and... humans or animals get sick sporadically, when, fo...lled PrPc change to harmful prions (called PrPSc).... of the brain that kills the victims within a matt...
...tors have long known that smokers rarely suffer fr...D) called ulcerative colitis, but they didn't know... Journal of Experimental Medicine might help expla...colleagues at the University of Pittsburgh now sho...
...ng adults with amblyopia, or lazy eye, can improve...treatment developed by researchers at USC and thre...n appears normal but does not see properly, even w...not develop fully, resulting in permanent loss of ...
...TREAL, December 20, 2005--Researchers have discove...ich reduce gastric acidity, are potential risk fac...f hospitals. The new research to be published in t...MA) tomorrow focuses on community-acquired C. diff...
health news:Carbon monoxide soothes inflammatory bowel disease 2health news:Adults with lazy eye can improve 2health news:Heart burn medication a risk factor for community-acquired C. difficile 2
... the National Patient Safety Foundation (NPSF).wil...nd build consensus around a.collaborative action p...n.leaders will participate, representing five key ...e FDA & Government, Medicine & Health Care Practit...
.In predicting violent behavior among teenagers, cliques and high school social.sets do matter, finds a new, large-scale study, the first to examine this factor.in a systematic manner. So does marijua
...ygrounds through partnership between health servic...dy).One way of improving safety in children's play...es to form a partnership in the surveillance of in...s, say researchers from Cardiff. Writing in this ...
...nts with refractory chronic lymphocytic.leukemia.D...une 12 ---ILEXTM Oncology, Inc. (NASDAQ: ILXO) and...nal results from an international,.multi-center, p... treatment of patients with B-cell.chronic lymphoc...
health news:NPSF workshop builds community to improve pharmaceutical safety 2health news:Study finds predictors for youth violence and drugs 2health news:Study finds predictors for youth violence and drugs 3health news:Study finds predictors for youth violence and drugs 4health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 2health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 3health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 4health news:ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia 5